Begin main content

Drug Reimbursement Recommendation - tafamidis (Vyndaqel)

Published on: February 21, 2020
Result type: News

Today, CADTH has issued final recommendations for:

tafamidis (Vyndaqel)

Indications: transthyretin-mediated amyloidosis
Recommendation: Reimburse with clinical criteria and/or conditions

For more information